Literature DB >> 4127020

Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

A G Sjöholm, A B Laurell.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4127020      PMCID： PMC1553814     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  28 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  THE INTERACTION BETWEEN CARRAGEENAN AND THE FIRST COMPONENT OF COMPLEMENT.

Authors:  T BORSOS; H J RAPP; C CRISLER
Journal:  J Immunol       Date:  1965-05       Impact factor: 5.422

3.  [Fibrin agar electrophoresis. 1. Description of the method].

Authors:  N HEIMBURGER; G SCHWICK
Journal:  Thromb Diath Haemorrh       Date:  1962-07-15

4.  Assay and properties of serum inhibitor of C'l-esterase.

Authors:  L R LEVY; I H LEPOW
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

5.  Studies on the role of Ca++ and Mg++ in complement fixation and immune hemolysis. III. The respective roles of Ca++ and Mg++ in immune hemolysis.

Authors:  L LEVINE; A G OSLER; M M MAYER
Journal:  J Immunol       Date:  1953-11       Impact factor: 5.422

6.  [In vitro studies on the mode of action and differences to heparin. Anticomplementary effect of a semisynthetic pentosan-polysulfo-ester].

Authors:  D Walb; M Loos; U Hadding
Journal:  Z Naturforsch B       Date:  1971-05       Impact factor: 1.047

7.  Effect of inhibitors on kinin-releasing activity of proteases.

Authors:  N Back; R Steger
Journal:  Fed Proc       Date:  1968 Jan-Feb

8.  Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.

Authors:  C D Forbes; J Pensky; O D Ratnoff
Journal:  J Lab Clin Med       Date:  1970-11

9.  C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; I H LEPOW
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

10.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307
View more
  9 in total

1.  Complement activity in middle ear effusions.

Authors:  J M Bernstein; H A Schenkein; R J Genco; W R Bartholomew
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

Review 2.  Activation of complement in relation to disease.

Authors:  J M Versey; L Slater; J R Hobbs
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

3.  Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S.

Authors:  B Dahlbäck
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

4.  Clinical applications of immunofixation: detection and quantitation of complement activation.

Authors:  J T Whicher; J Higginson; P G Riches; S Radford
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

5.  Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.

Authors:  E T Davies; B A Nasaruddin; A Alhaq; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

6.  Murine antigen H-2.7: localization of its antigenic determinant to the Ss (C4) molecule.

Authors:  C M Huang; J Klein
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

7.  Effect of treatment with 17 alpha-alkylated androgens on C4 conversion products in hereditary angioedema studied by crossed immunoelectrophoresis.

Authors:  L Bergamaschini; M Cicardi; A Tucci; A Agostoni
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

8.  Structural and functional differences between the H-2 controlled Ss and Slp proteins.

Authors:  A Ferreira; V Nussenzweig; I Gigli
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Human C4-binding protein. I. Isolation and characterization.

Authors:  J Scharfstein; A Ferreira; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.